“…Although two recent studies reported higher frequency of activating KIR genes, such as KIR2DS1, KIR2DS3 and KIR2DS4 in patients with CML and ALL [22,23], we couldn't reproduce these findings in our cohort. Our findings are thus in agreement with those reported from Babor et al, who also found very similar frequencies of KIR genes among haematological patients and healthy controls with European origin [24].…”